NO20083245L - Sykliske antimikrobielle peptider - Google Patents

Sykliske antimikrobielle peptider

Info

Publication number
NO20083245L
NO20083245L NO20083245A NO20083245A NO20083245L NO 20083245 L NO20083245 L NO 20083245L NO 20083245 A NO20083245 A NO 20083245A NO 20083245 A NO20083245 A NO 20083245A NO 20083245 L NO20083245 L NO 20083245L
Authority
NO
Norway
Prior art keywords
antimicrobial peptides
cyclic antimicrobial
cyclic
peptides
treatment
Prior art date
Application number
NO20083245A
Other languages
English (en)
Other versions
NO346186B1 (no
Inventor
Deborah O'neill
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0526120.1A external-priority patent/GB0526120D0/en
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Publication of NO20083245L publication Critical patent/NO20083245L/no
Publication of NO346186B1 publication Critical patent/NO346186B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Den foreliggende oppfinnelse relaterer til syklisk kationiske peptider og deres bruk i behandlingen av mikrobielle infeksjoner.
NO20083245A 2005-12-22 2006-12-21 Anvendelse av et syklisk peptid for fremstilling av et medikament for behandling eller forebyggelse av en soppinfeksjon. NO346186B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0526120.1A GB0526120D0 (en) 2005-12-22 2005-12-22 Therapeutic peptides
US77650506P 2006-02-24 2006-02-24
PCT/GB2006/004890 WO2007072037A1 (en) 2005-12-22 2006-12-21 Cyclic antimicrobial peptides

Publications (2)

Publication Number Publication Date
NO20083245L true NO20083245L (no) 2008-09-12
NO346186B1 NO346186B1 (no) 2022-04-11

Family

ID=37836928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083245A NO346186B1 (no) 2005-12-22 2006-12-21 Anvendelse av et syklisk peptid for fremstilling av et medikament for behandling eller forebyggelse av en soppinfeksjon.

Country Status (14)

Country Link
US (2) US8324154B2 (no)
EP (4) EP1976863B1 (no)
JP (3) JP5559477B2 (no)
KR (1) KR101413746B1 (no)
AU (1) AU2006327973B2 (no)
CA (1) CA2655448C (no)
CY (1) CY1113770T1 (no)
IL (2) IL192373A (no)
MX (1) MX2008008291A (no)
NO (1) NO346186B1 (no)
PL (1) PL1976863T3 (no)
RU (1) RU2463308C2 (no)
WO (1) WO2007072037A1 (no)
ZA (1) ZA200806329B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101413746B1 (ko) * 2005-12-22 2014-07-01 노바바이오틱스 리미티드 고리형 항균 펩타이드
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
US8303962B2 (en) * 2009-01-06 2012-11-06 C3 Jian, Inc. Antibacterial and antifungal peptides
EP2694085A4 (en) * 2011-04-01 2015-02-11 Univ Northeastern PROCESS FOR EXPLORING BACTERIAL CELL POPULATIONS
WO2013096823A1 (en) * 2011-12-21 2013-06-27 Regents Of The University Of Minnesota Cationic peptides and use of such peptides for inhibiting exotoxin production
KR101502797B1 (ko) * 2012-08-22 2015-03-17 연세대학교 산학협력단 신규한 양친매성　고리형 펩티드, 이의 제조방법 및 이를 포함하는 안정한 자기조립 나노전달체
US9082888B2 (en) 2012-10-17 2015-07-14 New York University Inverted orthogonal spin transfer layer stack
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
PT3149025T (pt) 2014-05-21 2019-08-01 Entrada Therapeutics Inc Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
US10017542B2 (en) * 2015-03-23 2018-07-10 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof
KR101692992B1 (ko) 2015-05-20 2017-01-17 연세대학교 산학협력단 고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
EP3746105A4 (en) 2018-01-29 2022-05-18 Ohio State Innovation Foundation CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN
US11576946B2 (en) 2018-01-29 2023-02-14 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-NFAT interaction
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
WO2019217682A1 (en) 2018-05-09 2019-11-14 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
KR20210151945A (ko) 2019-04-12 2021-12-14 립타이드 바이오사이언스, 인코포레이티드 대식세포 활성을 조정하기 위한 방법
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
CN115716865B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-酪-缬-亮肽及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
WO1994007529A1 (en) 1992-09-25 1994-04-14 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof
US6951652B2 (en) * 1998-07-29 2005-10-04 Biosynth S.R.L. Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
MXPA03010103A (es) * 2001-05-04 2004-03-10 Scripps Research Inst Peptidos y composiciones anti-microbianos.
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
AU2003228896A1 (en) * 2002-05-06 2003-11-17 The Scripps Research Institute Anti-microbial peptides and compositions
WO2004050685A2 (en) * 2002-11-29 2004-06-17 Adaptive Therapeutics, Inc. Antifungal therapeutic agents
US6783677B1 (en) * 2003-02-06 2004-08-31 Mayyar Systems, Inc. Anaerobic film biogas digester system
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
DK1927597T3 (en) 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
KR101413746B1 (ko) * 2005-12-22 2014-07-01 노바바이오틱스 리미티드 고리형 항균 펩타이드

Also Published As

Publication number Publication date
EP2348039A3 (en) 2011-08-24
IL240686A (en) 2017-07-31
US8324154B2 (en) 2012-12-04
NO346186B1 (no) 2022-04-11
AU2006327973A1 (en) 2007-06-28
ZA200806329B (en) 2009-12-30
IL192373A0 (en) 2008-12-29
IL240686A0 (en) 2015-10-29
HK1121462A1 (en) 2009-04-24
EP2357190A3 (en) 2011-08-24
EP2357191A3 (en) 2011-08-24
JP6050096B2 (ja) 2016-12-21
MX2008008291A (es) 2008-09-03
KR101413746B1 (ko) 2014-07-01
EP2357190A2 (en) 2011-08-17
KR20080081062A (ko) 2008-09-05
EP1976863A1 (en) 2008-10-08
WO2007072037A1 (en) 2007-06-28
US8785375B2 (en) 2014-07-22
CY1113770T1 (el) 2016-07-27
IL192373A (en) 2015-09-24
US20120316103A1 (en) 2012-12-13
RU2008129866A (ru) 2010-01-27
CA2655448A1 (en) 2007-06-28
JP6199797B2 (ja) 2017-09-20
EP2348039A2 (en) 2011-07-27
PL1976863T3 (pl) 2013-07-31
JP5559477B2 (ja) 2014-07-23
RU2463308C2 (ru) 2012-10-10
EP2357191A2 (en) 2011-08-17
EP1976863B1 (en) 2012-12-12
JP2013047268A (ja) 2013-03-07
WO2007072037A9 (en) 2009-03-05
CA2655448C (en) 2016-09-06
AU2006327973B2 (en) 2012-04-12
JP2014167010A (ja) 2014-09-11
US20090023641A1 (en) 2009-01-22
JP2009520794A (ja) 2009-05-28

Similar Documents

Publication Publication Date Title
CY1113770T1 (el) Κυκλικα αντι-μικροβιακα πεπτιδια
CY1123052T1 (el) Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa)
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
NO20092637L (no) Fremgangsmater for behandling
EA200870019A1 (ru) Лактамовые соединения и способы их применения
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
JO3416B1 (ar) تركيبات مضادة للبكتيريا وطرق استخدامها
EA201070271A1 (ru) Пептиды для получения вакцины
EA201170521A1 (ru) Новые соединения
EA200701825A1 (ru) Вакцины против хламидиоза
EA201000735A1 (ru) Композиции многотипных пептидов hpv и способы лечения или предотвращения папилломавирусной инфекции у человека
NO20082120L (no) Behandling og forebyggelse av mikroangiopati
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
EP3117832C0 (en) TREATMENT OF MICROBIAL INFECTIONS
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
NO20084852L (no) MGLUR5 modulatorer V
MY151051A (en) Vaccination against dengue virus infection
TNSN07240A1 (en) Compounds for flaviviridae treatment
EA201270568A1 (ru) Антимикробные композиции и способы их получения и применения
TW200630367A (en) Substituted adenines and the uses thereof
CR9109A (es) Tratamiento de mastitis
EA201500913A1 (ru) Противомикробные соединения и способы их получения и применения
EA200800206A1 (ru) Комбинированное применение метконазола и эпоксиконазола для уменьшения или предотвращения заражения зерновых культур микотоксинами